GEFISTERIS (Gefitinib)

May 30, 2023

Gefitinib (250 mg)
GEFISTERIS is a medication used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins called epidermal growth factor receptor (EGFR) tyrosine kinases.
EGFR is a protein that plays a role in the growth and spread of cancer cells. In some cases of NSCLC, there are genetic mutations in the EGFR gene that cause the receptors to be overly active, leading to uncontrolled cell growth and division. GEFISTERIS specifically targets and inhibits the activity of EGFR, blocking the signals that promote cancer cell growth.
STERIS PHARMA deals in Generic medicines that promotes healthy competition in the pharmaceutical industry, which can help to drive down prices and improve overall affordability.
For further information
please contact: info@sterispharma.com
Order now:
https://www.sterisonline.com/product/gefisteris-250-133658

SHARE WITH